Precision Medicine, CRISPR, and Genome Engineering

Lieferzeit: Lieferbar innerhalb 14 Tagen

213,99 

Moving from Association to Biology and Therapeutics, Advances in Experimental Medicine and Biology 1016

ISBN: 331963903X
ISBN 13: 9783319639031
Herausgeber: Stephen H Tsang
Verlag: Springer Verlag GmbH
Umfang: ix, 178 S., 4 s/w Illustr., 15 farbige Illustr., 178 p. 19 illus., 15 illus. in color.
Erscheinungsdatum: 21.11.2017
Auflage: 1/2017
Produktform: Gebunden/Hardback
Einband: Gebunden

This book presents descriptive overviews of gene editing strategies across multiple species while also offering in-depth insight on complex cases of application in the field of tissue engineering and regenerative medicine.  Chapters feature contributions from leaders in stem cell therapy and biology, providing a comprehensive view of the application of gene therapy in numerous fields with an emphasis on ophthalmology, stem cells, and agriculture. The book also highlights recent major technological advances, including ZFN, TALEN, and CRISPR. Precision Medicine, CRISPR, and Genome Engineering is part of the highly successful Advances in Experimental Medicine and Biology series. It is an indispensable resource for researchers and students in genetics as well as clinicians. 

Artikelnummer: 2527036 Kategorie:

Beschreibung

This handbook in gene editing is for novices and experts alike, as it will provide descriptive overviews of editing strategies across multiple species while also honing in on complex cases of application. Research from leaders in the fields of stem cell therapy and biology will be used to inform the work, which will focus on the major recent technological advances, including ZFN, TALEN, and CRISPR. The motif throughout the book will be gene therapy and its application in numerous fields, with an emphasis on ophthalmology, stem cells, and agriculture. The target audience will include researchers and students in genetics as well as clinicians, who will be drawn to the book by its applicability to their research and patients.

Autorenporträt

For years, Stephen Tsang has been culturing embryonic stem (ES) cells and created the first mouse model for a recessive form of retinitis pigmentosa by applying homologous recombination to ES cell technology. Two elements define his laboratory. First, by leveraging his genetics clinical practice, in which over 1000 retinal patients are cared for, he brings an array of clinical resources to his research, including stem cells and live imaging data. Second, he and his students are recognized authorities in a broad array of state-of-the-art technologies. Most recently, he was invited as a Moderator for the Gene Editing/Rewriting the Genome session during the 65th American Society of Human Genetics Annual Meeting.

Herstellerkennzeichnung:


Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

E-Mail: juergen.hartmann@springer.com

Das könnte Ihnen auch gefallen …